Literature DB >> 8975929

Interaction of Salmonella typhi strains with cultured human monocyte-derived macrophages.

D R Sizemore1, E A Elsinghorst, L C Eck, A A Branstrom, D L Hoover, R L Warren, F A Rubin.   

Abstract

Human monocyte-derived macrophages (MDM) provided this laboratory with a tool to develop a primary-cell assay for evaluating the relative virulence of newly constructed Salmonella typhi carrier strains. In this study, the interaction with and survival within MDM were compared for delta aroA143-attenuated strains, wild-type virulent strains, and the current oral-vaccine strain, Ty21a.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 8975929      PMCID： PMC174593          DOI： 10.1128/iai.65.1.309-312.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  15 in total

1.  Plasmodium falciparum: further characterization of a functionally active region of the merozoite invasion ligand EBA-175.

Authors:  B K Sim; J M Carter; C D Deal; C Holland; J D Haynes; M Gross
Journal:  Exp Parasitol       Date:  1994-05       Impact factor: 2.011

2.  Expression of host resistance to Salmonella typhi and Salmonella typhimurium: bacterial survival within macrophages of murine and human origin.

Authors:  I R Vladoianu; H R Chang; J C Pechère
Journal:  Microb Pathog       Date:  1990-02       Impact factor: 3.738

Review 3.  Live Salmonella as vaccines and carriers of foreign antigenic determinants.

Authors:  S N Chatfield; R A Strugnell; G Dougan
Journal:  Vaccine       Date:  1989-12       Impact factor: 3.641

4.  A galE via (Vi antigen-negative) mutant of Salmonella typhi Ty2 retains virulence in humans.

Authors:  D M Hone; S R Attridge; B Forrest; R Morona; D Daniels; J T LaBrooy; R C Bartholomeusz; D J Shearman; J Hackett
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

5.  Deletion of purE attenuates Brucella melitensis 16M for growth in human monocyte-derived macrophages.

Authors:  E S Drazek; H S Houng; R M Crawford; T L Hadfield; D L Hoover; R L Warren
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

6.  Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent.

Authors:  P I Fields; R V Swanson; C G Haidaris; F Heffron
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

7.  In vitro characterization of Salmonella typhi mutant strains for live oral vaccines.

Authors:  E M Dragunsky; E Rivera; H D Hochstein; I S Levenbook
Journal:  Vaccine       Date:  1990-06       Impact factor: 3.641

8.  Interleukin-1 and interleukin-6 gene expression in human monocytes stimulated with Salmonella typhimurium porins.

Authors:  M Galdiero; G Cipollaro de L'ero; G Donnarumma; A Marcatili; F Galdiero
Journal:  Immunology       Date:  1995-12       Impact factor: 7.397

9.  Genetic control of the innate resistance of mice to Salmonella typhimurium: expression of the Ity gene in peritoneal and splenic macrophages isolated in vitro.

Authors:  C R Lissner; R N Swanson; A D O'Brien
Journal:  J Immunol       Date:  1983-12       Impact factor: 5.422

10.  Primary structure of the 175K Plasmodium falciparum erythrocyte binding antigen and identification of a peptide which elicits antibodies that inhibit malaria merozoite invasion.

Authors:  B K Sim; P A Orlandi; J D Haynes; F W Klotz; J M Carter; D Camus; M E Zegans; J D Chulay
Journal:  J Cell Biol       Date:  1990-11       Impact factor: 10.539
View more
  8 in total

1.  Differential bacterial survival, replication, and apoptosis-inducing ability of Salmonella serovars within human and murine macrophages.

Authors:  W R Schwan; X Z Huang; L Hu; D J Kopecko
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

2.  Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death.

Authors:  A L Glasser; J Boudeau; N Barnich; M H Perruchot; J F Colombel; A Darfeuille-Michaud
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

3.  Quantitation of bacteria in bone marrow from patients with typhoid fever: relationship between counts and clinical features.

Authors:  J Wain; V B Pham; V Ha; N M Nguyen; S D To; A L Walsh; C M Parry; R P Hasserjian; V A HoHo; T H Tran; J Farrar; N J White; N P Day
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

4.  Evaluation of regulated delayed attenuation strategies for Salmonella enterica serovar Typhi vaccine vectors in neonatal and infant mice.

Authors:  Huoying Shi; Shifeng Wang; Roy Curtiss
Journal:  Clin Vaccine Immunol       Date:  2013-04-24

5.  Live recombinant Salmonella Typhi vaccines constructed to investigate the role of rpoS in eliciting immunity to a heterologous antigen.

Authors:  Huoying Shi; Javier Santander; Karen E Brenneman; Soo-Young Wanda; Shifeng Wang; Patti Senechal; Wei Sun; Kenneth L Roland; Roy Curtiss
Journal:  PLoS One       Date:  2010-06-18       Impact factor: 3.240

6.  Mechanisms of intrinsic resistance to antimicrobial peptides of Edwardsiella ictaluri and its influence on fish gut inflammation and virulence.

Authors:  Javier Santander; Taylor Martin; Amanda Loh; Camilo Pohlenz; Delbert M Gatlin; Roy Curtiss
Journal:  Microbiology (Reading)       Date:  2013-05-15       Impact factor: 2.777

7.  Comparative growth analysis of capsulated (Vi+) and acapsulated (Vi-) Salmonella typhi isolates in human blood.

Authors:  Sadia Liaquat; Yasra Sarwar; Aamir Ali; Abdul Haque
Journal:  EXCLI J       Date:  2015-02-09       Impact factor: 4.068

8.  Induction of Cell Cycle and NK Cell Responses by Live-Attenuated Oral Vaccines against Typhoid Fever.

Authors:  Christoph J Blohmke; Jennifer Hill; Thomas C Darton; Matheus Carvalho-Burger; Andrew Eustace; Claire Jones; Fernanda Schreiber; Martin R Goodier; Gordon Dougan; Helder I Nakaya; Andrew J Pollard
Journal:  Front Immunol       Date:  2017-10-12       Impact factor: 7.561
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.